API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2022/09/28/2523935/0/en/Karolinska-Development-s-portfolio-company-Umecrine-Cognition-presents-positive-results-from-a-preclinical-study-of-golexanolone.html
https://www.globenewswire.com/news-release/2022/09/14/2515677/0/en/Karolinska-Development-s-portfolio-company-Umecrine-Cognition-secures-funding-ahead-of-Phase-2-study-of-golexanolone-in-primary-biliary-cholangitis.html
https://www.globenewswire.com/news-release/2020/05/08/2030150/0/en/Karolinska-Development-s-portfolio-company-Umecrine-Cognition-presents-positive-additional-results-from-a-phase-2a-study-of-golexanolone.html
https://www.globenewswire.com/news-release/2020/04/03/2011609/0/en/Karolinska-Development-s-portfolio-company-Umecrine-Cognition-announces-results-from-a-phase-2a-clinical-study-of-golexanolone.html